Joseph Sgherza has been named vice president of biopharmaceutical development for the infectious disease franchise at Theorem Clinical Research.
 
Prior to joining the company, Mr. Sgherza was a portfolio director for PAREXEL International Corp., where he was responsible for the operational execution of pharmaceutical trials in infectious disease, biologics and oncology. He also served as executive vice president for SPRI Clinical Trials, where he hired and trained 78 team members in Eastern Europe for a new clinical research division, and conducted 15 clinical trial programs. He also held positions as head of clinical operations for Neeman Medical International, site management operations director for Duke Clinical Research, and senior manager of the worldwide anti-infective medical team for Pfizer.
 
“Joe is truly a leader in this area,” said Theorem president and chief executive officer John Potthoff. “He has developed and managed numerous global clinical programs in infectious diseases in all phases, from launch to patent expiration, and led clinical development teams to eight successful NDAs in infectious disease, hepatology and oncology.”